Important Advisories

Critical Notices

These notices are critical advisories about significant side effects and other risks.

• REMERON / REMERON RD (mirtazapine) associated with abnormal heart rhythm. (March 28/14)
• Do Not Use: Duloxetine (CYMBALTA). WorstPills.org reviews the dangers of this extremely popular drug and discusses why you should not use it to treat depression, anxiety or pain. (June 3/12) [paid subscription required].
• Antipsychotics linked to childhood diabetes. (November 22/11)
• STRATTERA (atomoxetine) associated with increased blood pressure and increased heart rate. (October 24/11)
• Citalopram: dose-related heart risk confirmed by Health Canada. (January 30/12)

Generally, these are newly announced (at the time indicated) and have not been included with the original literature that accompanied the medication.